methotrexate has been researched along with Venous Thromboembolism in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 7 (38.89) | 2.80 |
| Authors | Studies |
|---|---|
| Desai, RJ; Glynn, RJ; He, M; Kim, SC; Lee, H; Pawar, A; Solomon, DH; Weinblatt, ME | 1 |
| Boyce, EG; C Lui, M; Rogan, EL | 1 |
| Burmester, G; Charles-Schoeman, C; Curtis, JR; Dilley, D; Fleischmann, R; Liu, J; Mysler, E; Palac, H; Richez, C; Strengholt, S; Yamaoka, K | 1 |
| Charles-Schoeman, C; Choy, E; Curtis, JR; Khan, N; Lippe, R; McInnes, IB; Mysler, E; Nash, P; Palac, H; Shmagel, AK; Suboticki, J; Yamaoka, K | 1 |
| Avivi, I; Blumenthal, DT; Bokstein, F; Gibstein, L; Perry, C; Ram, R; Sarid, N; Weiss-Meilik, A | 1 |
| Bessette, L; Burmester, GR; Cohen, SB; Enejosa, JV; Hendrickson, B; Khan, N; Tanaka, Y; van Vollenhoven, RF; Winthrop, KL; Zerbini, CAF; Zhang, Y | 1 |
| Hasan, SS; Kow, CS | 1 |
| Galsky, MD; Gore, JL; Holt, SK; Ramos, JD; Schade, GR; Wright, JL; Yu, EY | 1 |
| Bessette, L; Durez, P; Fleischmann, R; Genovese, MC; Li, Y; Mysler, E; Ostor, AJ; Othman, AA; Pangan, AL; Peterfy, C; Song, IH; Zhou, Y | 1 |
| Franklin, JM; Glynn, RJ; Kim, SC; Liu, J; Schneeweiss, S; Solomon, DH | 1 |
| Biemond, BJ; Cornelissen, JJ; Coutinho, JM; Lauw, MN; Majoie, CB; Middeldorp, S; Stam, J; van der Holt, B; Zuurbier, SM | 1 |
| Ames, PR; Jawad, A; Merashli, M | 1 |
| Ballet, V; Bollen, L; Ferrante, M; Gils, A; van Assche, G; Vande Casteele, N; Vermeire, S | 1 |
| Francès, C | 1 |
| Altomare, M; Crescenzio, N; De Mattia, D; Del Vecchio, GC; Falanga, A; Giordano, P; Marchetti, M; Molinari, AC; Perutelli, P; Russo, G; Santoro, N; Saracco, P | 1 |
| Fayad, L; Gladish, G; Hagemeister, FB; Huen, A; Ji, Y; Teegala, S; Vadhan-Raj, S; Zhou, X | 1 |
| Ahlehoff, O; Gislason, G; Hansen, PR; Lindhardsen, J; Skov, L | 1 |
| Asaka, M; Hashino, S; Ibata, M; Imamura, M; Masauzi, N; Mashiko, S; Mori, A; Morioka, M; Tsutsumi, Y | 1 |
1 review(s) available for methotrexate and Venous Thromboembolism
| Article | Year |
|---|---|
Upadacitinib for the Treatment of Rheumatoid Arthritis: An Extensive Review.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Janus Kinase Inhibitors; Methotrexate; Randomized Controlled Trials as Topic; Venous Thromboembolism | 2023 |
4 trial(s) available for methotrexate and Venous Thromboembolism
| Article | Year |
|---|---|
Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme.
Topics: Adalimumab; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Herpes Zoster; Heterocyclic Compounds, 3-Ring; Humans; Methotrexate; Treatment Outcome; Venous Thromboembolism | 2023 |
Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Survival Rate; Venous Thromboembolism | 2021 |
Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme.
Topics: Adalimumab; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Drug Therapy, Combination; Herpes Zoster; Heterocyclic Compounds, 3-Ring; Humans; Methotrexate; Treatment Outcome; Venous Thromboembolism | 2021 |
Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Creatine Kinase; Double-Blind Method; Drug Therapy, Combination; Female; Herpes Zoster; Heterocyclic Compounds, 3-Ring; Humans; Infections; Janus Kinase Inhibitors; Male; Methotrexate; Middle Aged; Severity of Illness Index; Venous Thromboembolism | 2019 |
13 other study(ies) available for methotrexate and Venous Thromboembolism
| Article | Year |
|---|---|
Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study.
Topics: Aged; Arthritis, Rheumatoid; Cohort Studies; Female; Humans; Hydroxychloroquine; Incidence; Male; Medicare; Methotrexate; Propensity Score; Pulmonary Embolism; Risk Factors; United States; Venous Thromboembolism | 2021 |
MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Topics: Adalimumab; Arthritis, Psoriatic; Arthritis, Rheumatoid; Clinical Trials as Topic; Humans; Methotrexate; Spondylitis, Ankylosing; Venous Thromboembolism | 2023 |
Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19.
Topics: Anticoagulants; Colchicine; COVID-19 Drug Treatment; Heparin; Humans; Hydroxychloroquine; Methotrexate; Pharmaceutical Preparations; SARS-CoV-2; Venous Thromboembolism | 2021 |
Chemotherapy regimen is associated with venous thromboembolism risk in patients with urothelial tract cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Retrospective Studies; SEER Program; United States; Urologic Neoplasms; Venous Thromboembolism; Vinblastine | 2019 |
Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Comorbidity; Humans; Incidence; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Risk Factors; Venous Thromboembolism | 2015 |
Clinical Course of Cerebral Venous Thrombosis in Adult Acute Lymphoblastic Leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cerebrovascular Disorders; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Female; Headache; Humans; Injections, Spinal; Male; Methotrexate; Middle Aged; Netherlands; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Retrospective Studies; Risk Factors; Seizures; Spinal Puncture; Time Factors; Venous Thromboembolism; Venous Thrombosis; Young Adult | 2015 |
Venous thromboembolism as initial manifestation of adult onset Still's disease.
Topics: Adult; Anticoagulants; Drug Therapy, Combination; Humans; Male; Methotrexate; Prednisolone; Remission Induction; Still's Disease, Adult-Onset; Treatment Outcome; Venous Thromboembolism | 2015 |
Thromboembolism as an important complication of inflammatory bowel disease.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Pulmonary Embolism; Recurrence; Retrospective Studies; Severity of Illness Index; Venous Thromboembolism; Venous Thrombosis | 2016 |
[What's new in internal medicine?].
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Bacteriophages; Body Mass Index; Diabetes Complications; Drug Therapy, Combination; Humans; Hydroxychloroquine; Hypereosinophilic Syndrome; Hypertension; Immunosuppressive Agents; Internal Medicine; Methotrexate; Mimiviridae; Obesity; Risk Factors; Treatment Outcome; Venous Thromboembolism | 2008 |
Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparaginase; Case-Control Studies; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Fibrin Fibrinogen Degradation Products; Humans; Infant; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; P-Selectin; Plasminogen Activator Inhibitor 1; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Risk Factors; Thrombin; Thrombophilia; Venous Thromboembolism; Vincristine; von Willebrand Factor | 2010 |
Incidence and risk factors of venous thromboembolic events in lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Creatinine; Doxorubicin; Female; Hemoglobins; Humans; Incidence; Logistic Models; Lymphoma; Male; Methotrexate; Middle Aged; Pulmonary Embolism; Retrospective Studies; Risk Factors; Sex Factors; Venous Thromboembolism; Venous Thrombosis; Young Adult | 2010 |
[Patients with psoriasis have an increased risk of cardiovascular diseases].
Topics: Antirheumatic Agents; Atrial Fibrillation; Cardiovascular Diseases; Denmark; Humans; Immunosuppressive Agents; Methotrexate; Myocardial Infarction; Practice Guidelines as Topic; Psoriasis; Risk Factors; Venous Thromboembolism | 2012 |
Long-term administration of a low-molecular-weight heparin contributed to successful treatment in a patient with primary mediastinal large B-cell lymphoma and venous thromboembolism.
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Heparin, Low-Molecular-Weight; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Methotrexate; Prednisone; Rituximab; Venous Thromboembolism; Vincristine | 2008 |